GlassScriptPhysician profile
Stuart J Spechler
NPI 1033222955
$31,948.04
in general payments reported to CMS, 2019-2025
15 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,867 · 2021: $3,309 · 2022: $1,837 · 2023: $244 · 2024: $9,345 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,395 · Travel and Lodging: $827 · Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,395.00 |
| Travel and Lodging | $826.80 |
| Food and Beverage | $598.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $14,272.94 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $9,350.00 | 2021-2024 | |
| Astrazeneca Uk Limited | $3,759.00 | 2020 | |
| Lucid Diagnostics INC. | $3,098.10 | 2024-2025 | |
| Boston Scientific Corporation | $394.88 | 2019-2023 | Resolution 360 Clip |
| Medtronic, INC. | $316.75 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $160.35 | 2025 | Voquezna |
| Ethicon US, LLC | $146.44 | 2022 | |
| Erbe USA INC | $120.00 | 2019 | |
| Abbvie INC. | $108.20 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $81.41 | 2023-2024 | Dupixent |
| Sanofi-Aventis U.S. LLC | $70.26 | 2023 | |
| Genzyme Corporation | $29.02 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $28.78 | 2024 | Rebyota |
| Olympus America INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Spechler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.